Thiazolobenzimidazole: biological and biochemical anti-retroviral activity of a new nonnucleoside reverse transcriptase inhibitor. | Antiviral Res;21(3): 247-65, 1993 Jul. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Thiazolobenzimidazole: biological and biochemical anti-retroviral activity of a new nonnucleoside reverse transcriptase inhibitor.

Buckheit, R W; Hollingshead, M G; Germany-Decker, J; White, E L; McMahon, J B; Allen, L B; Ross, L J; Decker, W D; Westbrook, L; Shannon, W M.

Affiliation

Buckheit RW; Microbiology Research Department, Southern Research Institute, Birmingham, AL.

Antiviral Res ; 21(3): 247-65, 1993 Jul.

Article in En | MEDLINE | ID: mdl-7692815

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Thiazoles / Benzimidazoles / HIV-1 / Reverse Transcriptase Inhibitors Limits: Humans Language: En Journal: Antiviral Res Year: 1993 Document type: Article Affiliation country: Country of publication:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Thiazoles / Benzimidazoles / HIV-1 / Reverse Transcriptase Inhibitors Limits: Humans Language: En Journal: Antiviral Res Year: 1993 Document type: Article Affiliation country: Country of publication: